Select Page

Monoclonal Antibodies Infusion Program

Monoclonal Antibodies infusion Program for Covid patients is one of the more effective treatment options provided it is given timely and as prescribed.  Vascular Access nurses are pivotal to creating safe and timely IV Access to help ensure that the intravenous (IV) infusions are delivered effectively to the patients who need them.  Mobile vascular access companies may provide solutions to help facilitate treatment by augmenting understaffed, over-stretched, and exhausted nursing teams and Vascular Wellness provides such services.

What are Monoclonal Antibodies?

Monoclonal Antibodies are produced by pharmaceutical companies like other biologics medications and just like the name indicates, they are engineered or synthetic versions of antibodies similar to the antibodies produced by the body.  These antibodies are specifically designed to fight the Covid infection by adhering to the related spike protein to stop or mitigate the infection caused by Covid.  Early treatment with monoclonal antibodies appears to reduce emergency department patient needs, hospitalization, significant therapies, and death in Covid patients.  Treatment can also lower the extent of the virus in a person’s blood.  Unfortunately, due to supply constraints, treatment is limited or prioritized to people who have other major health concerns such as being immune-compromised.  Monoclonal Antibodies are considered safe but, are still being monitored.

What Monoclonal Antibodies are available for Covid?

Monoclonal Antibodies must evolve to keep up with the Covid virus mutations producing new variants.  As all viruses mutate, it is these mutations on the virus that were responsible for the Delta and later, Omicron variants, which now represent more than 99% of the Covid cases.  As of the beginning of February 2022, five Monoclonal Antibodies products have received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). They are: (1) Bamlanivimab plus Etesevimab; (2) Casirivimab plus Imdevimab; (3) Sotrovimab; (4) Tixageviamab plus Cilgavimab; and (5) Bebtelovimab.

Bamlanivimab plus Etesevimab and Casirivimab plus Imdevimab that both were effective against the Delta variant have been found to be mostly ineffective against the latest Omicron variant. Sotrovimab, Tixageviamab plus Cilgavimab, and Bebtelovimab appear effective against the Omicron variant although more data are needed for the Tixageviamab and Cilgavimab combination, which is made by AstraZeneca.

GlaxoSmithKline is the maker of Sotrovimab and it is delivered as an IV infusion.  Subject to the treating physician’s prescription and treatment plan, Sotrovimab is generally given as a single intravenous (IV) infusion of 500mg that must be given as quickly as possible after testing positive for Covid and within 10 days of symptom onset.  Eli Lilly is the maker of Bebtelovimab and is effective within 7 days of infection. This is a shorter time window than Sotrovimab and highlights the importance of early diagnosis and treatment.

What Antiviral Drugs are available for Covid?

Antiviral drugs are also available via pill and infusion to help Covid patients.  Remdesivir is an antiviral medication delivered by IV Infusion over 3 days and which must be started as soon as possible and within 7 days of onset.  Use of Remdesivir has expanded from treating hospitalized inpatient Covid patients to non-hospitalized outpatient Covid patients with the risk of severe disease progression.  This anti-viral medication targets the viral enzyme of Covid, rendering it unable to duplicate in the host (human).

Monoclonal Antibodies Infusion Program by Vascular Wellness

Monoclonal Antibodies Infusion Program by Vascular Wellness provides the highest quality and most innovative, effective, and timely healthcare similar to all its other vascular access standard and advanced services including clinical consultation, line placement, program management, training, education, and infection consulting and prevention.  Prompt, efficient, and successful vascular access continues to be highly critical to ensuring that all patients are able to receive effective treatment with Monoclonal Antibodies and Antiviral drugs that require IV Infusion.  Each Monoclonal Antibodies and Antiviral treatment protocol is different and having a dependable, on-call, on-demand, and on-site mobile provider can help ensure treatment is done on-time and correctly.  At a high level, the typical infusion takes about 45 minutes and Vascular Wellness clinicians and local nursing staff will monitor the patient before, during and after treatment.

Vascular Wellness Monoclonal Antibodies Infusion Program can also include pre-exposure treatment.  Prophylaxis, preventive treatment, is usually given to patients in the form of Monoclonal Antibodies, who are either immunocompromised, or not able to make the necessary antibodies after vaccination for protection, or not able to be fully vaccinated.  With its flexibility for inpatient or outpatient, Vascular Wellness can efficiently provide services to these patients to help prevent serious Covid issues should such patients become infected.

Given the current stress on healthcare providers and facilities, especially in the area of bedside nursing and Vascular Access Teams or PICC Teams, augmenting or outsourcing to Vascular Wellness makes sense even if primarily for a Monoclonal Antibodies Infusion program.  Vascular Wellness has experience in setting up and establishing programs that seamlessly integrate with the current provider’s clinical and non-clinical staff and systems, and such programs can be used on both an inpatient and outpatient basis.  Generally, these programs facilitate more patient services with improved patient outcomes.  In the case of a hospital, by facilitating faster therapy, these programs can reduce patient length of stay and create higher bed turnover enabling more patient services.  Finally, Vascular Wellness has found that its costs are generally more than offset by reimbursements and payments and thus, outsourcing to Vascular Wellness has little to no budgetary impact.

Vascular Wellness understands that virtually all care stars with vascular access, and we are a trusted partner to provide it timely and effectively.  We are a team of collaborative, courageous, and innovative people whose focus on quality and thirst for advancing healthcare and nursing sets us apart.  We care deeply about each other, each patient, each client, and our relationship with the healthcare and local community.  We are experts in our field who help people and make a difference in all lives we touch.  Our vision of Advancing Healthcare and Empowering Nurses, and our core values of Integrity, Quality, Innovation, and Teamwork, drive us to provide the most comprehensive solutions in the market and why we have developed Monoclonal Antibodies Infusion Programs for our clients, and why we want to help others do the same. You can trust us to deliver your Monoclonal Antibodies Infusion Program including Antivirals effectively and efficiently.

If you require Vascular Access or want to learn more about our Monoclonal Antibodies Infusion Programs, speak to the team at Vascular Wellness today.

Vascular Wellness Serves North CarolinaSouth Carolina, and Virginia and expanding to GeorgiaKentuckyOhioTennessee, and West Virginia.


Looking for more than just a PICC Service?

We offer timely, innovative, and advanced vascular access services at the bedside, with full administrative support, from skilled employees who care.